Evaluation Glizigen® and Ocoxin®-Viusid® in High-grade Cervical Intraepithelial Lesions
Catalysis SL
Catalysis SL
University Medical Center Groningen
University of Copenhagen
Tel-Aviv Sourasky Medical Center
Tongji Hospital
Huazhong University of Science and Technology
University Medical Centre Maribor
Peking Union Medical College Hospital
Peking Union Medical College Hospital
Alkü Alanya Education and Research Hospital
NHS Greater Glasgow and Clyde
Shenzhen People's Hospital
Tianjin Medical University Cancer Institute and Hospital
Maastricht University Medical Center
Zhujiang Hospital
Erasmus Medical Center
THEVAX Genetics Vaccine
Genexine, Inc.
Seoul St. Mary's Hospital
Barretos Cancer Hospital
Asan Medical Center
Taipei Medical University
Shanghai First Maternity and Infant Hospital
University of Witwatersrand, South Africa
Brookdale University Hospital Medical Center
National Cancer Institute (NCI)
HealthBanks Biotech Co., Ltd.
McMaster University
The University of Hong Kong
University of Copenhagen
National Taiwan University Hospital